149 related articles for article (PubMed ID: 6413214)
21. Variegate porphyria: past, present and future.
Frank J; Christiano AM
Skin Pharmacol Appl Skin Physiol; 1998; 11(6):310-20. PubMed ID: 10343202
[TBL] [Abstract][Full Text] [Related]
22. Organization of the terminal two enzymes of the heme biosynthetic pathway. Orientation of protoporphyrinogen oxidase and evidence for a membrane complex.
Ferreira GC; Andrew TL; Karr SW; Dailey HA
J Biol Chem; 1988 Mar; 263(8):3835-9. PubMed ID: 3346226
[TBL] [Abstract][Full Text] [Related]
23. Fluorometric assays for coproporphyrinogen oxidase and protoporphyrinogen oxidase.
Labbe P; Camadro JM; Chambon H
Anal Biochem; 1985 Aug; 149(1):248-60. PubMed ID: 3907404
[TBL] [Abstract][Full Text] [Related]
24. Reduced ferrochelatase activity: a defect common to porphyria variegata and protoporphyria.
Becker DM; Viljoen JD; Katz J; Kramer S
Br J Haematol; 1977 Jun; 36(2):171-9. PubMed ID: 871431
[TBL] [Abstract][Full Text] [Related]
25. Multiple mechanisms for the regulation of haem synthesis during erythroid cell differentiation. Possible role for coproporphyrinogen oxidase.
Conder LH; Woodard SI; Dailey HA
Biochem J; 1991 Apr; 275 ( Pt 2)(Pt 2):321-6. PubMed ID: 2025219
[TBL] [Abstract][Full Text] [Related]
26. Reduced ferrochelatase activity in fibroblasts from patients with porphyria variegata.
Viljoen DJ; Cayanis E; Becker DM; Kramer S; Dawson B; Bernstein R
Am J Hematol; 1979; 6(3):185-90. PubMed ID: 484541
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of mammalian protoporphyrinogen oxidase by acifluorfen.
Corrigall AV; Hift RJ; Adams PA; Kirsch RE
Biochem Mol Biol Int; 1994 Dec; 34(6):1283-9. PubMed ID: 7697001
[TBL] [Abstract][Full Text] [Related]
28. New aspects of porphyrias.
Mascaro JM; Lecha M; Herrero C; Muniesa AM
Curr Probl Dermatol; 1985; 13():11-32. PubMed ID: 3882335
[No Abstract] [Full Text] [Related]
29. Molecular characterization of porphyrias in Italy: a diagnostic flow-chart.
Martinez di Montemuros F; Di Pierro E; Patti E; Tavazzi D; Danielli MG; Biolcati G; Rocchi E; Cappellini MD
Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):867-76. PubMed ID: 12699245
[TBL] [Abstract][Full Text] [Related]
30. Reconstitution of the two terminal enzymes of the heme biosynthetic pathway into phospholipid vesicles.
Ferreira GC; Dailey HA
J Biol Chem; 1987 Mar; 262(9):4407-12. PubMed ID: 3558411
[TBL] [Abstract][Full Text] [Related]
31. Induction of terminal enzymes for heme biosynthesis during differentiation of mouse erythroleukemia cells.
Taketani S; Yoshinaga T; Furukawa T; Kohno H; Tokunaga R; Nishimura K; Inokuchi H
Eur J Biochem; 1995 Jun; 230(2):760-5. PubMed ID: 7607249
[TBL] [Abstract][Full Text] [Related]
32. The genetic basis of "Scarsdale Gourmet Diet" variegate porphyria: a missense mutation in the protoporphyrinogen oxidase gene.
Frank J; Poh-Fitzpatrick MB; King LE; Christiano AM
Arch Dermatol Res; 1998 Aug; 290(8):441-5. PubMed ID: 9763307
[TBL] [Abstract][Full Text] [Related]
33. Cloning, sequence, and expression of mouse protoporphyrinogen oxidase.
Dailey TA; Dailey HA; Meissner P; Prasad AR
Arch Biochem Biophys; 1995 Dec; 324(2):379-84. PubMed ID: 8554330
[TBL] [Abstract][Full Text] [Related]
34. A spectrum of novel mutations in the protoporphyrinogen oxidase gene in 13 families with variegate porphyria.
Frank J; Jugert FK; Merk HF; Kalka K; Goerz G; Anderson K; Bickers DR; Poh-Fitzpatrick MB; Christiano AM
J Invest Dermatol; 2001 May; 116(5):821-3. PubMed ID: 11348478
[No Abstract] [Full Text] [Related]
35. Kinetic properties of the membrane-bound human liver mitochondrial protoporphyrinogen oxidase.
Camadro JM; Abraham NG; Levere RD
Arch Biochem Biophys; 1985 Oct; 242(1):206-12. PubMed ID: 4051500
[TBL] [Abstract][Full Text] [Related]
36. Homozygous variegate porphyria: identification of mutations on both alleles of the protoporphyrinogen oxidase gene in a severely affected proband.
Frank J; McGrath J; Lam H; Graham RM; Hawk JL; Christiano AM
J Invest Dermatol; 1998 Apr; 110(4):452-5. PubMed ID: 9540991
[TBL] [Abstract][Full Text] [Related]
37. Heme metabolism in erythroid and hepatic cells.
Ibraham NG; Friedland ML; Levere RD
Prog Hematol; 1983; 13():75-130. PubMed ID: 6366915
[No Abstract] [Full Text] [Related]
38. Decreased leukocyte ferrochelatase activity in erythropoietic protoporphyria.
Kondo M; Ohe M; Mizuguchi M
J Dermatol; 1989 Apr; 16(2):116-21. PubMed ID: 2778187
[TBL] [Abstract][Full Text] [Related]
39. A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria.
Meissner PN; Dailey TA; Hift RJ; Ziman M; Corrigall AV; Roberts AG; Meissner DM; Kirsch RE; Dailey HA
Nat Genet; 1996 May; 13(1):95-7. PubMed ID: 8673113
[TBL] [Abstract][Full Text] [Related]
40. Coproporphyrinogen oxidase, protoporphyrinogen oxidase and ferrochelatase activities in iron-overloaded and ethanol-treated rats.
Li F; Lim CK; Peters TJ
Biomed Chromatogr; 1990 Nov; 4(6):253-6. PubMed ID: 2289051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
